Bain Capital-backed Heartflow prices $317m IPO

Heartflow is advancing coronary care by transforming coronary artery disease into a screenable, diagnosable, and manageable condition.

8 August 2025•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.